LogicBio Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
LogicBio Therapeutics, Inc. quarterly Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2022.
  • LogicBio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2022 was -0.18 USD/shares, a 41.9% increase year-over-year.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 +$0.13 +41.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 +$0.18 +54.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.